See the DrugPatentWatch profile for cosentyx

Cosentyx, also known as secukinumab, is a medication used to treat several conditions, including psoriasis [1]. The dosage for psoriasis is typically 300 mg, which is administered via injection [1].

However, the specific amount of secukinumab in each injection can vary depending on the formulation and the device used for administration. For instance, Cosentyx is available in both a prefilled syringe and a Sensoready pen, and the amount of medication in each device may differ [1].

The Cosentyx Sensoready pen, for example, contains 150 mg of secukinumab in 1 mL of solution [2]. Therefore, to administer a 300 mg dose, a patient would need to use two Sensoready pens.

It's important to note that the dosage and administration of Cosentyx should be determined by a healthcare professional, and patients should follow the instructions provided by their healthcare provider or the medication's label [1].

In summary, while the typical dosage for psoriasis is 300 mg, the amount of secukinumab in each injection can vary. Patients should consult with their healthcare provider for specific instructions on dosage and administration.

Sources:

[1] Cosentyx (secukinumab) [Internet]. Drugs.com. Drugs.com; 2022 [cited 2023 Feb 22]. Available from: <https://www.drugs.com/cosentyx.html>.

[2] Secukinumab (Cosentyx) [Internet]. DrugPatentWatch. DrugPatentWatch; 2023 [cited 2023 Feb 22]. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.